Top

BMC Health Services Research

Published in:

Open Access 01-12-2012 | Research article

Acute care utilization due to hospitalizations for pediatric lower respiratory tract infections in British Columbia, Canada

Authors: Pablo Santibanez, Katherine Gooch, Pamela Vo, Michelle Lorimer, Yurik Sandino

Published in: BMC Health Services Research | Issue 1/2012

Abstract

Background

Pediatric LRTI hospitalizations are a significant burden on patients, families, and healthcare systems. This study determined the burden of pediatric LRTIs on hospital settings in British Columbia and the benefits of prevention strategies as they relate to healthcare resource demand.

Methods

LRTI inpatient episodes for patients <19 years of age during 2008–2010 were extracted from the BC Discharge Abstract Database. The annual number of acute care beds required to treat pediatric LRTIs was estimated. Sub-analyses determined the burden due to infants <1 year of age and high-risk infants. Population projections were used to forecast LRTI hospitalizations and the effectiveness of public health initiatives to reduce the incidence of LRTIs to 2020 and 2030.

Results

During 2008–2010, LRTI as the primary diagnosis accounted for 32.0 and 75.9% hospitalizations for diseases of the respiratory system in children <19 years of age and infants <1 year of age, respectively. Infants <1 year of age accounted for 47 and 77% hospitalizations due to pediatric LRTIs and pediatric LRTI hospitalizations specifically due to respiratory syncytial virus (RSV), respectively. The average length of stay was 3.1 days for otherwise healthy infants <1 year of age and 9.1 days for high-risk infants (P <0.0001). 73.1% pediatric LRTI hospitalizations occurred between November and April. Over the study timeframe, 19.6 acute care beds were required on average to care for pediatric LRTIs which increased to 64.0 beds at the peak of LRTI hospitalizations. Increases in LRTI bed-days of 5.5 and 16.2% among <19 year olds by 2020 and 2030, respectively, were predicted. Implementation of appropriate prevention strategies could cause 307 and 338 less LRTI hospitalizations in <19 year olds in 2020 and 2030, respectively.

Conclusion

Pediatric LRTI hospitalizations require significant use of acute care infrastructure particularly between November and April. Population projections show the burden may increase in the next 20 years, but implementation of effective public health prevention strategies may contribute to reducing the acute care demand and to supporting efforts for overall pediatric healthcare sustainability.

Available only for authorised users

Simoes EA, Carbonell-Estrany X: Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J. 2003, 22: S13-S20.PubMed

Langley JM, Wang EEL, Law BJ, Stephens D, Boucher FD, Dobson S, McDonald J, MacDonald NE, Mitchell I, Robinson JL: Economic evaluation of respiratory syncytial virus infection in Canadian children: a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. J Pediatr. 1997, 131: 113-117. 10.1016/S0022-3476(97)70133-1.CrossRefPubMed

Shi N, Palmer L, Chu BC, Katkin JP, Hall CB, Masaquel AS, Mahadevia PJ: Association of RSV lower respiratory tract infection and subsequent healthcare use and costs: a Medicaid claims analysis in early-preterm, late-preterm, and full-term infants. J Med Econ. 2011, 14 (3): 335-340. 10.3111/13696998.2011.578188.CrossRefPubMed

Paes BA, Mitchell I, Banerji A, Lanctot KL, Langley JM: A decade of respiratory syncytial virus epidemiology and prophylaxis: Translating evidence into everyday clinical practice. Can Respir J. 2011, 18 (2): e10-e19.CrossRefPubMedPubMedCentral

Law BJ, Carbonell-Estrany X, Simoes EA: An update on respiratory syncytial virus epidemiology: a developed country perspective. Respir Med. 2002, 96 (SB): S1-S7.CrossRefPubMed

Langley JM, LeBlanc JC, Smith B, Wang EE: Increasing incidence of hospitalization for bronchiolitis among Canadian children, 1980–2000. J Infect Dis. 2003, 188 (11): 1764-1767. 10.1086/379740.CrossRefPubMed

Schanzer DL, Langley JM, Tam TW: Hospitalization attributable to influenza and other viral respiratory illnesses in Canadian children. Pediatr Infect Dis J. 2006, 25: 795-800. 10.1097/01.inf.0000232632.86800.8c.CrossRefPubMed

Panozzo CA, Fowlkes AL, Anderson LJ: Variation in the timing of respiratory syncytial virus outbreaks. Lessons from national surveillance. Pediatr Infect Dis J. 2007, 26: S41-S45. 10.1097/INF.0b013e318157da82.CrossRefPubMed

Canadian Critical Care Trials Group H1N1 Collaborative: Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA. 2009, 302 (17): 1872-1879. 10.1001/jama.2009.1496.CrossRef

10.

SteelFisher GK, Blendon RJ, Bekheit MM, Lubell K: The public’s response to the 2009 H1N1 influenza pandemic. N Engl J Med. 2010, 362 (22): e65-10.1056/NEJMp1005102.CrossRefPubMed

11.

Goldman RD, Vohra S, Rogovik AL: Vitamin use among children attending a Canadian pediatric emergency department. Fundam Clin Pharmacol. 2011, 25 (1): 131-137. 10.1111/j.1472-8206.2010.00816.x.CrossRefPubMed

12.

Goldman RD, Vohra S, Rogovik AL: Potential vitamin-drug interactions in children: at a pediatric emergency department. Paediatr Drugs. 2009, 11 (4): 251-257. 10.2165/00148581-200911040-00004.CrossRefPubMed

13.

BC Stats: Population extrapolation for organization planning with less error (p.e.o.p.l.e.), run cycle 35. 2010, Victoria, British Columbia: British Columbia Ministry of Management Services

14.

Canadian Institute for Health Information: Discharge abstract database (DAD), acute care hospitalizations for the province of British Columbia. 2011

15.

World Health Organization: International Statistical Classification of Disease and Related Health Problems, Tenth Revision (ICD-10). 2010, Geneva: World Health Organization

16.

Simoes EA: Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr. 2003, 143: S118-S126. 10.1067/S0022-3476(03)00511-0.CrossRefPubMed

17.

MedCalc software, version 12.1. Mariakerke, Belgium, http://www.medcalc.org/.

18.

Ryan MAK, Christian RS, Wohlrabe J: Hand washing and respiratory illness among young adults in military training. Am J Prev Med. 2001, 21 (2): 79-83. 10.1016/S0749-3797(01)00323-3.CrossRefPubMed

19.

Wang EEL, Law BJ, Boucher FD, Stephens D, Robinson JL, Dobson S, Langley JM, McDonald J, MacDonald NE, Mitchell I: Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1996, 129 (3): 390-395. 10.1016/S0022-3476(96)70071-9.CrossRefPubMed

20.

Sampalis JS: Morbidity and mortality after RSV-associated hospitalizations among premature Canadian infants. J Pediatr. 2003, 143 (S5): S150-S156.CrossRefPubMed

21.

Stewart DL, Romero JR, Buysman EK, Fernandes AW, Mahadevia PJ: Total healthcare costs in the US for preterm infants with respiratory syncytial virus lower respiratory infection in the first year of life requiring medical attention. Curr Med Res Opin. 2009, 25: 2795-2804.CrossRefPubMed

22.

Statistics Canada: Population projections for Canada, provinces and territories 2009–2036. Catalogue no. 91-520-X. 2010, Ottawa, Ontario: Statistics Canada

23.

Isaacs D, Dickson H, O’Callaghan C, Sheaves R, Winter A, Moxon ER: Hand washing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus. Arch Dis Child. 1991, 66: 227-231. 10.1136/adc.66.2.227.CrossRefPubMedPubMedCentral

24.

Austin J: Preventing respiratory syncytial virus in homebound premature infants. Home Healthc Nurse. 2007, 25: 429-432. 10.1097/01.NHH.0000281609.58553.7f.CrossRefPubMed

25.

Russell FM, Buttery J: Vaccine development for capsulate bacteria causing pneumonia. Curr Opinion Pul Med. 2003, 9: 227-232. 10.1097/00063198-200305000-00012.CrossRef

26.

The IMpact-RSV Study Group: Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998, 102 (3 Pt1): 531-537.CrossRef

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6963/12/451/prepub

Title: Acute care utilization due to hospitalizations for pediatric lower respiratory tract infections in British Columbia, Canada
Authors: Pablo Santibanez
Katherine Gooch
Pamela Vo
Michelle Lorimer
Yurik Sandino
Publication date: 01-12-2012
Publisher: BioMed Central
Published in: BMC Health Services Research / Issue 1/2012
Electronic ISSN: 1472-6963
DOI: https://doi.org/10.1186/1472-6963-12-451

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Acute care utilization due to hospitalizations for pediatric lower respiratory tract infections in British Columbia, Canada

Abstract

Background

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2012

Monitoring the prevalence of chronic conditions: which data should we use?

Personal factors influence use of cervical cancer screening services: epidemiological survey and linked administrative data address the limitations of previous research

Using financial incentives to increase initial uptake and completion of HPV vaccinations: protocol for a randomised controlled trial

Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians

Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China

Sustainability of healthcare innovations (SUSHI): long term effects of two implemented surgical care programmes (protocol)